8-K
false000153117700015311772022-06-082022-06-08

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 8, 2023

 

 

Sight Sciences, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40587

80-0625749

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

4040 Campbell Avenue

Suite 100

 

Menlo Park, California

 

94025

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 877 266-1144

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

SGHT

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 


 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 8, 2023, Sight Sciences, Inc. (the “Company”) held its annual meeting of stockholders. A total of 41,709,886 shares of the Company’s common stock were present in person or represented by proxy at the meeting, representing approximately 86.1% of the Company’s common stock outstanding as of April 11, 2023, the record date. Set forth below are the voting results for the proposals considered and voted upon at the meeting, each of which are described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 26, 2023.

 

Item 1 – Election of two Class II directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until each such director’s respective successor has been duly elected and qualified or until each such director’s earlier death, resignation or removal.

 

 

Votes FOR

Votes WITHHELD

Broker Non-Votes

Staffan Encranz

25,200,595

10,308,666

6,200,625

Catherine Mazzacco

 

 

35,458,052

 

 

 

51,209

 

 

 

6,200,625

 

 

Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.

 

Votes FOR

Votes AGAINST

Votes ABSTAINED

Broker Non-Votes

41,688,515

4,435

16,936

0

 

Based on the foregoing votes, Staffan Encrantz and Catherine Mazzacco were elected as Class II directors, and the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was duly ratified.

 

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Sight Sciences, Inc.

 

 

 

 

Date:

June 12, 2023

By:

/s/ Paul Badawi

 

 

 

President and Chief Executive Officer